Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

10.03p
   
  • Change Today:
    -0.100p
  • 52 Week High: 36.50
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 1,060,887
  • Market Cap: £41.35m
  • Beta: 0.04

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart (19-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -720.0% -33.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a 0.1
Pr/Revenue 10.3 1.5
Pr/Book 1.0  
Latest F'cast
Revenue n/a 586.9%
PBT n/a n/a
EPS n/a -50.7%
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.00 (26.40) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 4.00 (29.00) (8.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 27.47 (9.10) (3.94)p n/a n/a -51% n/a 0.0%
31-Dec-26 36.58 (12.03) (1.88)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Final Results 19-May-2025 07:00 RNS
Notice of investor presentations 06-May-2025 07:00 RNS
Notice of Results 15-Apr-2025 14:00 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 10.03p
Change Today -0.100p
% Change -0.99 %
52 Week High 36.50
52 Week Low 9.55
Volume 1,060,887
Shares Issued 412.47m
Market Cap £41.35m
Beta 0.04

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.11% above the market average20.11% above the market average20.11% above the market average20.11% above the market average20.11% above the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average
Price Trend
85.84% below the market average85.84% below the market average85.84% below the market average85.84% below the market average85.84% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-May-2025

Time Volume / Share Price
16:18 2,500 @ 9.80p
15:35 125,000 @ 9.95p
15:31 125,000 @ 9.99p
14:48 9,350 @ 10.01p
14:26 20,833 @ 9.87p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page